FIELD: medicine. SUBSTANCE: method involves treating control and case tumor cell cultures in vitro with 3H-timidine. Individual chemosensitivity index is to be calculated and label index is to be photooptically determined. Primary short-life tumor cell cultures are to be used in exponential growth phase instead of survival cuts. EFFECT: enhanced reliability of test results.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINATION OF INDIVIDUAL TUMOR CHEMIOSENSITIVITY IN PATIENTS IN VITRO | 1994 |
|
RU2094802C1 |
| METHOD OF TISSUES CULTIVATION IN VITRO | 0 |
|
SU1791452A1 |
| HUMAN EMBRYONIC RHABDOMYOSARCOMA CELL LINE 862 RMSAR KDD | 2020 |
|
RU2737248C1 |
| OSTEOGENIC HUMAN SARCOMA CELL LINE 793 OSSAR RVV | 2019 |
|
RU2722867C1 |
| MOUSE SPINDLE CELL SARCOMA CELL LINE 164 MSar FE | 2023 |
|
RU2796351C1 |
| METHOD FOR TUMOUR GROWTH INHIBITION | 2012 |
|
RU2491930C1 |
| IMMUNOSTIMULATING AGENT | 1998 |
|
RU2145500C1 |
| METHOD FOR DETERMINING MEDICINAL SENSITIVITY OF NONSMALL CELL LUNG CANCER IN VITRO | 2021 |
|
RU2766662C1 |
| GLYCOPROTEIN TCF-II AND PHARMACEUTICAL COMPOSITION CONTAINING EFFECTIVE AMOUNT OF GLYCOPROTEIN TCF-II | 1991 |
|
RU2097432C1 |
| HUMAN COLORECTAL CANCER CELL LINE 485 COLO CAN | 2017 |
|
RU2650757C1 |
